Significance of borderline HbA2 levels in β thalassemia carrier screening
Open Access
- 30 March 2022
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-10
Abstract
Increased HbA2 levels are the characteristic feature of β-thalassemia carriers. A subset of carriers however do not show HbA2 levels in the typical carrier range (≥ 4.0%) but show borderline HbA2 levels. As a result, these carriers escape diagnosis and carry the risk of having β-thalassemia major offspring. Borderline HbA2 values may occur as a consequence of mild β-thalassemia mutations, co-inherited β-thalassemia and α- or δ- thalassemia or iron deficiency anemia. However, there is insufficient knowledge regarding the cause of borderline HbA2 levels in specific populations. This study aimed to identify the determinants of borderline HbA2 levels (which we have considered as HbA2 3.0–3.9%) in 205 individuals. Primary screening involved detecting the presence of iron deficiency anemia followed by molecular analysis of α, β and δ globin genes. Remarkably, 168 of 205 individuals were positive for a defect. 87% (149/168) of positive individuals were heterozygous for β thalassemia with (59/149) or without (90/149) the presence of co-existing IDA, α or δ gene defects. Notably, 20 of 149 β thalassemia carriers showed HbA2 < 3.5% and MCV > 80fL. 7 of these 20 carriers were married to carriers of hemoglobinopathies. Our findings describe the genetic basis of borderline HbA2 levels and emphasize the necessity of a molecular diagnosis in these individuals in the routine clinical setting.Keywords
Funding Information
- Department of Biotechnology, Ministry of Science and Technology, India
- Lady Tata Memorial Trust, India
This publication has 37 references indexed in Scilit:
- Problems in determining thalassemia carrier status in a program for prevention and control of severe thalassemia syndromes: a lesson from ThailandClinical Chemistry and Laboratory Medicine (CCLM), 2013
- Hemoglobin A2 Lowered by Iron Deficiency and α-Thalassemia: Should Screening Recommendation for β-Thalassemia Change?ISRN Hematology, 2013
- Role of Novel and Rare Nucleotide Substitutions of the β-Globin GeneThalassemia Reports, 2012
- Molecular Diversity of Hemoglobin H Disease in IndiaAmerican Journal of Clinical Pathology, 2010
- The role of haemoglobin A2 testing in the diagnosis of thalassaemias and related haemoglobinopathiesJournal of Clinical Pathology, 2008
- Prevalence and Molecular Characterization of α-Thalassemia Syndromes among IndiansGenetic Testing, 2008
- Mutational spectrum of delta‐globin gene in the Portuguese populationEuropean Journal of Haematology, 2007
- The effect of iron deficiency anaemia on the levels of haemoglobin subtypes: possible consequences for clinical diagnosisClinical and Laboratory Haematology, 2002
- Genotype of subjects with borderline hemoglobin A2 levels: Implication for, β‐thalassemia carrier screeningAmerican Journal of Hematology, 1994
- Hematological Phenotype of the Double Heterozygous State for Alpha and Beta ThalassemiaHemoglobin, 1984